Earn rewards for your opinion on lab products.

Get exclusive insights into life science trends.

Stay up to date on research news.

Health organizations form consortium for gene therapy development
October 29, 2021 -- The U.S. Food and Drug Administration, the National Institutes of Health, and other organizations are joining forces to increase the development of gene therapies for rare diseases. Read More
Opportunities for cell and gene therapy companies to partner with early investors
October 28, 2021 -- Cell and gene therapy firms are some of the hottest investment opportunities currently in the market, according to Chris Garabedian, CEO of Xontogeny and the portfolio manager of PXV Fund. Garabedian recently spoke with ScienceBoard.net about his investment strategy. Read More
Scientists uncover how nitric oxide fights pathogens indirectly
October 27, 2021 -- Scientists have determined the mechanism by which the immune system defends against pathogens using the molecule nitric oxide, which occurs naturally in the human body, according to a paper published on October 22 in Immunity. The findings may lead to new therapies for inflammatory conditions or infectious diseases. Read More
Filling a gap so biotech startups can advance to the next level
October 26, 2021 -- In the biotechnology industry, there is a need for capital among companies that are already commercial and have products with demonstrated success but that might not yet be profitable. BroadOak Capital fills the gap for biotech companies between venture capital and private equity, according to partner Bill Snider who spoke with ScienceBoard.net. Read More
Clinical trial optimization in CGT can help make cardiovascular therapies a reality
October 25, 2021 -- ScienceBoard.net caught up with Dr. Monica Shah, who is vice president of medical strategy and head of the Cell and Gene Therapy (CGT) Center of Excellence at IQVIA, at Meeting on the Mesa. Shah moderated "Personalizing Cardiovascular Therapies to Address the Underlying Causes of Disease" on day two of the meeting. Read More
Lessons learned help the cell and gene therapy industry deliver products to patients
October 22, 2021 -- On the second day of the Cell & Gene Meeting on the Mesa, Betty Woo, PhD, vice president and general manager of cell and gene therapy at Thermo Fisher Scientific, led a workshop titled "Industrialization of Cell Therapy Manufacturing -- Lessons Learned From Biologics." ScienceBoard.net caught up with Woo following the workshop. Read More
How can the cell and gene therapy field industrialize collaboration?
October 21, 2021 -- Adlai Goldberg, the global life sciences digital, social, and commercial innovation leader at Ernst & Young, led a workshop on "Unlocking the Power of Collaboration to Fuel the Industry Transformation for Cell and Gene Therapies" at the 2021 Cell & Gene Meeting on the Mesa. Goldberg called on the cell and gene therapy industry to adopt a mindset of co-collaboration. Read More
5 takeaways from the Cell & Gene Meeting on the Mesa
October 21, 2021 -- In this final episode of our coverage from the 2021 Cell & Gene Meeting on the Mesa, hosted by the Alliance for Regenerative Medicine, ScienceBoard.net Editor-in-Chief Samantha Black, PhD, discusses five takeaways from the event. Read More
Early engagement with regulatory agencies is key to therapeutic development
October 20, 2021 -- Next-generation advanced therapies call for novel regulatory approaches, according to Mark Lane, PhD, vice president, development consulting and scientific affairs, of Biopharma Excellence by PharmaLex. Lane moderated a panel discussion titled "Innovative Regulatory Pathways for Next-Generation Treatments" at the 2021 Cell & Gene Meeting on the Mesa. Read More
New platform identifies best viral vectors for gene therapy
October 20, 2021 -- Researchers have developed a novel computational platform that identifies the best viral vector to deliver a gene therapy to its target. The technology, described October 19 in eLife, promises to speed development of adeno-associated virus-mediated gene therapies against vision loss and other disorders. Read More
Bacteria use 'belt and braces' defense system vs. bacteriophages
October 19, 2021 -- Researchers have shown how a plasmid in the bacterium Escherichia fergusonii uses a "belt and braces" approach to defend itself against bacteriophages. The breakthrough, published on October 18 in Nucleic Acids Research, could lead to new DNA-targeting biotechnology tools. Read More
Cardiovascular cell, gene therapy leaders discuss nascent field
October 18, 2021 -- The emerging field of cardiovascular cell and gene therapies shows great promise to significantly improve clinical outcomes, but it still faces key challenges, according to an October 13 plenary session at the Cell & Gene Meeting on the Mesa. Read More
CGTBO editor comments on trends from Cell & Gene Meeting on the Mesa
October 18, 2021 -- Blake Middleton, editor of Cell & Gene Therapy Business Outlook (CGTBO), was joined by Bruce Carlson, senior vice president of publications at Science and Medicine Group, to review the latest developments in therapies from the 2021 Cell  & Gene Meeting on Mesa. Read More
Machine Bio crowned as BioTools Innovator champion
October 15, 2021 -- CARLSBAD, CA - Machine Bio co-founder and CEO David Marash delivered an impassioned pitch that resulted in the protein synthesis company being named the inaugural winner of the BioTools Innovator Competition. Read More
Opportunities abound in cell and gene therapy for discerning investors
October 14, 2021 -- CARLSBAD, CA - There are more opportunities in the cell and gene therapy sector than ever before. But to profit from them, investors must be more discerning than in the past, according to a panel of investors at the Cell & Gene Meeting on the Mesa on October 14. Read More